IB Acquisition Corp. (IBACR) stock

IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$0.10−0.00 (-3.50%)

Close on Oct 30, 2026Market cap $54.39MP/E –Yield –

IB Acquisition revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

IB Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.